• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Isis Pharmaceuticals

Isis Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Sickle Cell Disease Pipeline Review, H2 2015 - Research and Markets

    Sickle Cell Disease Pipeline Review, H2 2015 - Research and Markets

  2. UPDATE: Five things that terrorize us, but shouldn't

    UPDATE: Five things that terrorize us, but shouldn't

  3. British Woman Convicted of Joining Islamic State

    British Woman Convicted of Joining Islamic State

  4. ISIS Said to Have 'Industry of Fake Passports'

    ISIS Said to Have 'Industry of Fake Passports'

  5. Could this surprising factor save oil from Iran-fueled slide?

    Could this surprising factor save oil from Iran-fueled slide?

  6. Woeful earnings threaten to intensify stock-market bloodbath

    Woeful earnings threaten to intensify stock-market bloodbath

  7. Woeful earnings threaten to intensify stock-market bloodbath

    Woeful earnings threaten to intensify stock-market bloodbath

  8. Fund manager who's been right on oil has a depressing new prediction

    Fund manager who's been right on oil has a depressing new prediction

  9. Fund manager who's been right on oil has a depressing new prediction

    Fund manager who's been right on oil has a depressing new prediction

  10. Fund manager who's been right on oil has a depressing new prediction

    Fund manager who's been right on oil has a depressing new prediction

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.